Home

Noxopharm Limited

ASX Code

NOX

Sector

Pharmaceuticals- Biotechnology & Life Sciences

Investor Centre

https://www.noxopharm.com/site/investors/share-price

Website

https://www.noxopharm.com/site/content/

About

Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company. The clinical stage drug candidate is Veyonda^® (previously known as NOX-66). Veyonda^® is a first-in-class, dual-acting cytotoxic and immuno-oncology drug candidate designed to enhance the effectiveness and safety of both chemotherapy and radiotherapy.

News

Noxopharm (ASX: NOX) - Webinar Presentation

Noxopharm Study Finds its Drug Improves Prostate Cancer Survival Rates

Noxopharm (ASX:NOX) - Hidden Gems Webinar Presentation